Astrazeneca Us Trial Data

• AstraZeneca says COVID-19 vaccine now 76% effective after updating U.S. trial data

  U.S. health officials earlier in the week publicly rebuked the drugmaker for using "outdated information" when calculating that the vaccine was 79 per cent effective.

  Health

  Mar 24, 2021
  
• Health Canada adding AstraZeneca blood clot warning, but says vaccine is safe

  The warning in Canada would centre on what to look for, including intense or persistent headaches, shortness of breath and pain in the legs.

  Canada

  Mar 23, 2021
  
• Advertisement
• Can AstraZeneca’s reputation be saved? Experts worry ‘unforced errors’ erode trust

  Coupled with earlier missteps in reporting data and a recent blood clot scare, experts said the new stumble could cause lasting harm to the shot that is key to global efforts.

  World

  Mar 23, 2021
• Advertisement
• AstraZeneca data from U.S. vaccine trial may be outdated, incomplete: health agency

  U.S. authorities said they were "concerned" about the information AstraZeneca provided from the trial, which initially claimed the COVID-19 vaccine is 79 per cent effective.

  Health

  Mar 23, 2021
• AstraZeneca vaccine trials in U.S. confirm shot is safe, highly effective

  AstraZeneca said its experts did not identify any safety concerns related to the vaccine, including finding no increased risk of rare blood clots identified in Europe.

  Science

  Mar 22, 2021